1. 1. Fakhri N, Chad MA, Lahkim M, Houari A, Dehbi H, Belmouden A, et al. (2022) Risk factors for breast cancer in women: an update review. Med Oncol, 39(12): 197. [DOI:10.1007/s12032-022-01804-x]

2. Bartels SAL, Donker M, Poncet C, Sauve N, Straver ME, van de Velde CJH, et al. (2023) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS Trial. J Clin Oncol, 41(12): 2159-65. [DOI:10.1200/JCO.22.01565]

3. Garcia-Etienne CA, Ferrari A, Della Valle A, Lucioni M, Ferraris E, Di Giulio G, et al. (2020) Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center. Eur J Surg Oncol, 46(1): 15-23. [DOI:10.1016/j.ejso.2019.08.013]

4. Jimenez-Gomez M, Loro-Perez J, Vega-Benitez V, Hernandez-Hernandez JR, Aguirre NA (2023) Axillary management in patients with breast cancer and positive axilla at diagnosis. Experience in a Spanish university hospital with a 5-year follow-up. J Cancer Res Ther, 19(2): 183-90. [DOI:10.4103/jcrt.jcrt_263_22]

5. Ling DC, Iarrobino NA, Champ CE, Soran A, Beriwal S (2020) Regional recurrence rates with or without complete axillary dissection for breast cancer patients with node-positive disease on sentinel lymph node biopsy after neoadjuvant chemotherapy. Adv Radiat Oncol, 5(2): 163-70. [DOI:10.1016/j.adro.2019.09.006]

6. Wu J, Lu AD, Zhang LP, Zuo YX, Jia YP (2019) Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi, 40(1): 52-7.

7. Reed DR, Lindsley SK, Mann GN, Austin-Seymour M, Korssjoen T, Anderson BO, et al. (2005) Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys, 61(2): 358-64. [DOI:10.1016/j.ijrobp.2004.06.006]

8. Jacobson G, Bunda-Randall N, Wen S, Miller M (2017) Axillary lymph node coverage with 3-dimensional tangential field irradiation and correlation with heart and lung dose. Adv Radiat Oncol, 2(4): 630-5. [DOI:10.1016/j.adro.2017.07.005]

9. Nitsche M, Temme N, Forster M, Reible M, Hermann RM (2014) Tangential vs defined radiotherapy in early breast cancer treatment without axillary lymph node dissection: a comparative study. Strahlenther Onkol, 190(8): 715-21. [DOI:10.1007/s00066-014-0681-6]

10. Alco G, Igdem SI, Ercan T, Dincer M, Senturk R, Atilla S, et al. (2010) Coverage of axillary lymph nodes with high tangential fields in breast radiotherapy. Br J Radiol, 83(996): 1072-6. [DOI:10.1259/bjr/25788274]

11. Seppala J, Heikkila J, Myllyoja K, Koskela K (2015) Volumetric modulated arc therapy for synchronous bilateral whole breast irradiation - A case study. Rep Pract Oncol Radiother, 20(5): 398-402. [DOI:10.1016/j.rpor.2015.05.011]

12. Bi S, Zhu R, Dai Z (2022) Dosimetric and radiobiological comparison of simultaneous integrated boost radiotherapy for early stage right side breast cancer between three techniques: IMRT, hybrid IMRT and hybrid VMAT. Radiat Oncol, 17(1): 60. [DOI:10.1186/s13014-022-02009-2]

13. Rossi M, Boman E, Kapanen M (2019) Contralateral tissue sparing in lymph node-positive breast cancer radiotherapy with VMAT technique. Med Dosim, 44(2): 117-21. [DOI:10.1016/j.meddos.2018.03.005]

14. Shao WC, Yin HT, Zhang H. (2022) Assessment of vital organ dose in volumetric intensity modulated arc therapy for left and right breast cancer. Int J Radiat Res, 20(4): 761-5.

15. Arslan A, Aktas E, Eren SK, Dengiz I, Arslan SA, Güney Y (2023) Dosimetric comparison of the heart substructures with IMRT and VMAT techniques in left breast radiotherapy: The effect of deep inspiratory breath-hold. Int J Radiat Res, 21(1): 23-30.

16. Viren T, Heikkila J, Myllyoja K, Koskela K, Lahtinen T, Seppala J (2015) Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy. Radiat Oncol, 10: 79. [DOI:10.1186/s13014-015-0392-x]

17. Byrne M, Archibald-Heeren B, Hu Y, Fong A, Chong L, Teh A (2018) Comparison of semiautomated tangential VMAT with 3DCRT for breast or chest wall and regional nodes. J Appl Clin Med Phys, 19(5): 684-93. [DOI:10.1002/acm2.12442]

18. Boman E, Rossi M, Haltamo M, Skytta T, Kapanen M (2016) A new split arc VMAT technique for lymph node positive breast cancer. Phys Med, 28: s1120-1797 (16) 30954-1. [DOI:10.1016/j.ejmp.2016.10.012]

19. Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete Sola A, et al. (2015) ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol, 114(1): 3-10. [DOI:10.1016/j.radonc.2014.11.030]

20. Paddick I and Lippitz B (2006) A simple dose gradient measurement tool to complement the conformity index. J Neurosurg, 105 Suppl: 194-201. [DOI:10.3171/sup.2006.105.7.194]

21. Shaw E, Kline R, Gillin M, Souhami L, Hirschfeld A, Dinapoli R, et al. (1993) Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys, 27(5): 1231-9. [DOI:10.1016/0360-3016(93)90548-A]

22. Castelo M, Hu SY, Dossa F, Acuna SA, Scheer AS (2020) Comparing observation, axillary radiotherapy, and completion axillary lymph node dissection for management of axilla in breast cancer in patients with positive sentinel nodes: A systematic review. Ann Surg Oncol, 27(8): 2664-76. [DOI:10.1245/s10434-020-08225-y]

23. Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. (2023) NCCN Guidelines(R) Insights: Breast Cancer, Version 4.2023. J Natl Compr Canc Netw, 21(6): 594-608. [DOI:10.6004/jnccn.2023.0031]

24. Keenan LG, Lavan N, Dunne M, McArdle O (2019) Modifiable risk factors for acute skin toxicity in adjuvant breast radiotherapy: Dosimetric analysis and review of the literature. Med Dosim, 44(1): 51-5. [DOI:10.1016/j.meddos.2018.01.004]

25. Qiu J, Zhang S, Lv B, Zheng X (2021) Cardiac dose control and optimization strategy for left breast cancer radiotherapy with non-uniform VMAT technology. Technol Cancer Res Treat, 20: 15330338211053752. [DOI:10.1177/15330338211053752]

26. Liu ZM, Ge XL, Chen JY, Wang PP, Zhang C, Yang X, et al. (2015) Adjuvant radiotherapy after breast conserving treatment for breast cancer: a dosimetric comparison between volumetric modulated arc therapy and intensity modulated radiotherapy. Asian Pac J Cancer Prev, 16(8): 3257-65. [DOI:10.7314/APJCP.2015.16.8.3257]

27. Zhang Q, Yu XL, Hu WG, Chen JY, Wang JZ, Ye JS, et al. (2015) Dosimetric comparison for volumetric modulated arc therapy and intensity-modulated radiotherapy on the left-sided chest wall and internal mammary nodes irradiation in treating post-mastectomy breast cancer. Radiol Oncol, 49(1): 91-8. [DOI:10.2478/raon-2014-0033]

28. Xie Y, Bourgeois D, Guo B, Zhang R (2020) Postmastectomy radiotherapy for left-sided breast cancer patients: Comparison of advanced techniques. Med Dosim, 45(1): 34-40. [DOI:10.1016/j.meddos.2019.04.005]

29. Popescu CC, Olivotto IA, Beckham WA, Ansbacher W, Zavgorodni S, Shaffer R, et al. (2010) Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys, 76(1): 287-95. [DOI:10.1016/j.ijrobp.2009.05.038]

30. Seo I and Jang H (2022) Increased second primary liver cancer risk in young breast cancer patients undergoing radiotherapy and chemotherapy: a nationwide population-based study. Int J Radiat Res, 20(2): 291-7. [DOI:10.52547/ijrr.20.2.6]

31. Jang H, Baek JG, Kim W, Sohn JH (2021) Assessment of intensity modulated radiation therapy in left breast cancer including regional nodes without the internal mammary node: secondary cancer risks on thyroid and stomach. Int J Radiat Res, 19(4): 921-8. [DOI:10.52547/ijrr.19.4.19]

32. Abo-Madyan Y, Aziz MH, Aly MM, Schneider F, Sperk E, Clausen S, et al. (2014) Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer. Radiother Oncol, 110(3): 471-6. [DOI:10.1016/j.radonc.2013.12.002]

33. Lee B, Lee S, Sung J, Yoon M (2014) Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT. J Radiol Prot, 34(2): 325-31. [DOI:10.1088/0952-4746/34/2/325]

34. Fogliata A, De Rose F, Franceschini D, Stravato A, Seppala J, Scorsetti M, et al. (2018) Critical appraisal of the risk of secondary cancer induction from breast radiation therapy with volumetric modulated arc therapy relative to 3D conformal therapy. Int J Radiat Oncol Biol Phys, 100(3): 785-93. [DOI:10.1016/j.ijrobp.2017.10.040]

35. Yin Y, Chen J, Sun T, Ma C, Lu J, Liu T, et al. (2012) Dosimetric research on intensity-modulated arc radiotherapy planning for left breast cancer after breast-preservation surgery. Med Dosim, 37(3): 287-92. [DOI:10.1016/j.meddos.2011.11.001]

36. Tsai PF, Lin SM, Lee SH, Yeh CY, Huang YT, Lee CC, et al. (2012) The feasibility study of using multiple partial volumetric-modulated arcs therapy in early stage left-sided breast cancer patients. J Appl Clin Med Phys, 13(5): 3806. [DOI:10.1120/jacmp.v13i5.3806]

37. Liu H, Chen X, He Z, Li J. (2016) Evaluation of 3D-CRT, IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study. Comput Med Imaging Graph, 54: 1-5. [DOI:10.1016/j.compmedimag.2016.10.001]

38. Chun M, Joon An H, Kwon O, Oh DH, Park JM, Kim JI (2019) Impact of plan parameters and modulation indices on patient-specific QA results for standard and stereotactic VMAT. Phys Med, 62: 83-94. [DOI:10.1016/j.ejmp.2019.05.005]

39. Park JM, Kim JI, Park SY (2019) Modulation indices and plan delivery accuracy of volumetric modulated arc therapy. J Appl Clin Med Phys, 20(6): 12-22. [DOI:10.1002/acm2.12589]